Alys Adamski
Overview
Explore the profile of Alys Adamski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
462
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gupta A, Lam B, Zerbey S, Rosovsky R, Lake L, Dodge L, et al.
Blood Vessel Thromb Hemost
. 2025 Jan;
1(4).
PMID: 39868029
No abstract available.
2.
Repp A, Sparks A, Wilkinson K, Roetker N, Schaefer J, Li A, et al.
J Thromb Haemost
. 2024 Sep;
22(12):3521-3531.
PMID: 39260742
Background: Although guidelines recommend risk assessment for hospital-acquired venous thromboembolism (HA-VTE) to inform prophylaxis decisions, studies demonstrate inappropriate utilization of pharmacoprophylaxis in hospitalized medical patients. Predictors of pharmacoprophylaxis initiation in...
3.
Peseski A, Kapoor S, Kuchibhatla M, Adamski A, Abe K, Beckman M, et al.
Res Pract Thromb Haemost
. 2024 May;
8(4):102420.
PMID: 38817950
Background: Cancer-associated venous thromboembolism (CA-VTE) represents a major cause of morbidity and mortality in patients with cancer. Despite poor outcomes, there is an ongoing knowledge gap in epidemiologic data related...
4.
Lam B, Dodge L, Zerbey S, Robertson W, Rosovsky R, Lake L, et al.
Sci Rep
. 2024 May;
14(1):12010.
PMID: 38796561
Venous thromboembolism (VTE) is the leading cause of preventable death in hospitalized patients. Artificial intelligence (AI) and machine learning (ML) can support guidelines recommending an individualized approach to risk assessment...
5.
Lam B, Chrysafi P, Chiasakul T, Khosla H, Karagkouni D, McNichol M, et al.
Blood Adv
. 2024 Mar;
8(12):2991-3000.
PMID: 38522096
Venous thromboembolism (VTE) is a leading cause of preventable in-hospital mortality. Monitoring VTE cases is limited by the challenges of manual medical record review and diagnosis code interpretation. Natural language...
6.
Lam B, Zerbey S, Pinson A, Robertson W, Rosovsky R, Lake L, et al.
Res Pract Thromb Haemost
. 2024 Jan;
7(8):102272.
PMID: 38169996
No abstract available.
7.
Chiasakul T, Lam B, McNichol M, Robertson W, Rosovsky R, Lake L, et al.
Eur J Haematol
. 2023 Oct;
111(6):951-962.
PMID: 37794526
Background: Accurate diagnostic and prognostic predictions of venous thromboembolism (VTE) are crucial for VTE management. Artificial intelligence (AI) enables autonomous identification of the most predictive patterns from large complex data....
8.
Lam B, Dodge L, Datta S, Rosovsky R, Robertson W, Lake L, et al.
Res Pract Thromb Haemost
. 2023 Sep;
7(6):102168.
PMID: 37767063
Background: Venous thromboembolism (VTE) is a leading cause of preventable mortality among hospitalized patients, but appropriate risk assessment and thromboprophylaxis remain underutilized or misapplied. Objectives: We conducted an electronic survey...
9.
Wendelboe A, Saber I, Dvorak J, Adamski A, Feland N, Reyes N, et al.
JMIR Bioinform Biotechnol
. 2023 May;
3(1):e36877.
PMID: 37206160
Background: Venous thromboembolism (VTE) is a preventable, common vascular disease that has been estimated to affect up to 900,000 people per year. It has been associated with risk factors such...
10.
Huang Y, Yusuf H, Adamski A, Hsu J, Baggs J, Auf R, et al.
J Thromb Thrombolysis
. 2022 Dec;
55(1):189-194.
PMID: 36515793
The association between thromboembolic events (TE) and COVID-19 infection is not completely understood at the population level in the United States. We examined their association using a large US healthcare...